Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 4

1(33.3%)

3Total

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05303350Withdrawn

Comparison of the Effectiveness of a Web Fracture Liaison Service (e_FLS) to Fracture Liaison Services in France: the evAB Study (evAB)

Role: collaborator

NCT06259890Not ApplicableRecruiting

Influence of Sodium Intake in spondyLoarthriTes

Role: collaborator

NCT04530682Completed

COVID-19 in Rheumatic Inflammatory Diseases Under Immuno-suppressive Drugs

Role: collaborator

NCT05593640Unknown

Thromboxane A2 and Osteoarthritis

Role: collaborator

NCT03838939Not ApplicableCompleted

Biotherapies and Therapeutic Education in Chronic Inflammatory Rheumatism

Role: collaborator

NCT00794404Completed

Evaluation of Power Doppler US Technique for the Diagnosis of Spondylarthropathy

Role: collaborator

NCT00780793Phase 4Completed

Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study

Role: collaborator

All 7 trials loaded